CordLife aims high in India after opening its first local blood bank
This article was originally published in Clinica
Executive Summary
Singapore-based CordLife is currently doing R&D on cord blood therapies with centres in Australia, the Netherlands and Indonesia. On successful completion of clinical trials, these therapies will be introduced into India through hospital and clinical partners who are currently being identified, the firm told Clinica.